ZNF592 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 8.86746231998359E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.39219999984297E-07 |
Normal-vs-Stage2 |
1.68217999999554E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.967640E-02 |
Stage1-vs-Stage2 |
6.787800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.968600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.539200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.02520003597562E-09 |
Normal-vs-AfricanAmerican |
1.095010E-01 |
Normal-vs-Asian |
6.32840000402979E-08 |
Caucasian-vs-AfricanAmerican |
2.095600E-01 |
Caucasian-vs-Asian |
5.856600E-01 |
AfricanAmerican-vs-Asian |
3.009200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.52795999999178E-05 |
Normal-vs-Female |
1.01609999969554E-07 |
Male-vs-Female |
1.449790E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.795500E-03 |
Normal-vs-Extreme_Weight |
1.22680000047559E-07 |
Normal-vs-Obese |
4.117800E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.789800E-01 |
Normal_Weight-vs-Obese |
1.561550E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.439200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.760400E-01 |
Normal-vs-Age(41-60Yrs) |
4.248300E-04 |
Normal-vs-Age(61-80Yrs) |
2.00299998809328E-09 |
Normal-vs-Age(81-100Yrs) |
3.028600E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.289700E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.756200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.700600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.855000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.809200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.314600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.175200E-01 |
Normal-vs-Grade 3 |
7.474800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
5.549200E-01 |
Grade 2-vs-Grade 4 |
9.175200E-01 |
Grade 3-vs-Grade 4 |
7.474800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.95950050524618E-10 |
Normal-vs-N1 |
2.584000E-02 |
N0-vs-N1 |
9.112300E-02 |
|
|